Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 17, 2023
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
[ Mon, Jul 17th 2023
] - WOPRAI
Jacob Johnson Maintained (WST) at Buy with Increased Target to $420 on, Jul 17th, 2023
Jacob Johnson of Stephens & Co., Maintained "West Pharmaceutical Services, Inc." (WST) at Buy with Increased Target from $400 to $420 on, Jul 17th, 2023.
Jacob has made no other calls on WST in the last 4 months.
There is 1 other peer that has a rating on WST. Out of the 1 peers that are also analyzing WST, 0 agree with Jacob's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jacob
- Derik De Bruin of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $405 on, Friday, June 16th, 2023
